Clearant Inc.

Who Are We?		Press Releases
Clearant, Inc. is on the leading edge of innovation in the soft tissue allograft market backed by over a decade of research and development with an unwavering commitment to the safety of patients. Clearant sterilizes human tissue (biologics and non-biologics) for transplantation using a patented and proprietary process (The Clearant Process ®). The allografts are used in a wide variety of surgical procedures in the areas of sports medicine, orthopedic, dental, spine and other surgical specialties

Global Soft Tissue Allografts Market to Reach US$2.35 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Soft Tissue Allografts market. The global market for soft tissue allografts is forecast to reach US$2.35 billion by the year 2015. Key factors driving market growth include Read More...

Soft Tissue Allograft is tissue that is transplanted from one person (a donor) to another person (the recipient). Soft tissue allografts include tendons, ligaments, cartilage, bone among others, all of which are used to help patients in a variety of surgical specialties i.e orthopedic.

Who Are We?

Press Releases